Clinical Trials Browser

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Depression

NCT04520139 2026-04-29

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Phase 1/2 Not yet recruiting

102 enrolled

Gynecologic

Chemotherapy-Related Cognitive Impairment, Ovarian Neoplasms, Cognitive Dysfunction

NCT07465497 2026-03-12

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Phase NA Enrolling by invitation

80 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT02290834 2026-03-11

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

Phase NA Recruiting

200 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognition Disorders

NCT07443514 2026-03-02

Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma

Phase NA Recruiting

3 enrolled

Lymphoid

Chemotherapy-Related Cognitive Impairment, Lymphoma, Large B-Cell, Diffuse

NCT04586530 2026-01-21

TAMS

Phase NA Active not recruiting

220 enrolled

Chemotherapy-Related Cognitive Impairment, Cognition Disorders

NCT06950190 2025-08-12

(ECCPC)

Phase 3 Enrolling by invitation

100 enrolled

Chemotherapy-Related Cognitive Impairment, Neurotoxicity Syndromes, Cognitive Dysfunction

NCT07017530 2025-06-12

CHEMO-CogEx

Phase NA Not yet recruiting

220 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Motor Activity

NCT06662474 2024-10-30

Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches

Phase NA Not yet recruiting

120 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT05239663 2024-08-01

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

Phase 3 Terminated

76 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT06435559 2024-05-30

CHEMOFOG

Phase NA Unknown

128 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT05909813 2024-05-16

Individualized Piano Instruction (IPI) for Improving Cognition in Breast Cancer Survivors.

Phase NA Completed

6 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT06312969 2024-03-15

WINNERS

Phase NA Unknown

56 enrolled

Chemotherapy-Related Cognitive Impairment

NCT06103318 2024-03-06

ICOgnition

Phase NA Unknown

176 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT06234150 2024-02-20

ADANC

Phase NA Not yet recruiting

90 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT05941598 2023-07-14

Electroacupuncture for Chemotherapy-Related Cognitive Impairment

Phase 2 Unknown

100 enrolled

Chemotherapy-Related Cognitive Impairment

NCT04092647 2023-06-15

Ashwagandha for Cognitive Dysfunction

Phase 2 Unknown

80 enrolled

Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction

NCT05409248 2022-06-08

Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors

Phase NA Unknown

120 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Cognitive Dysfunction

NCT04230863 2021-10-05

Neuroplasticity-Based Cognitive Remediation for Chemotherapy-Related Cognitive Impairment

Phase NA Completed

21 enrolled

Chemotherapy-Related Cognitive Impairment, Cognitive Dysfunction

NCT04789187 2021-03-12

ECCO

Phase NA Unknown

126 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Motor Activity, Neoplasms

NCT03324945 2020-11-12

Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients

Phase NA Completed

14 enrolled

Chemotherapy-Related Cognitive Impairment

NCT02312934 2020-01-21

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Phase 2 Completed

22 enrolled 14 charts

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms

NCT01205503 2016-02-24

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Phase 2 Completed

32 enrolled 24 charts

BreastLymphoid

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Lymphoma, Non-Hodgkin

NCT00387062 2008-06-24

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

Phase 1 Completed

50 enrolled

Breast

Chemotherapy-Related Cognitive Impairment, Breast Neoplasms, Memory Disorders, Neurobehavioral Manifestations, Cognitive Dysfunction

NCT00047476 2005-06-24

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients

Phase 2 Completed

160 enrolled

Chemotherapy-Related Cognitive Impairment, Fatigue, Memory Disorders, Neoplasms

Clinical Trials

Evaluation of Cognitive Education Activities in Breast Cancer Patients Receiving Chemotherapy

Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT

Impact of Supplementation With Synbiotics and Prebiotics on Cognitive Decline Associated With Neoadjuvant Chemotherapy in First-line Patients With Breast Cancer

Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast Cancer

Cognitive Impairment in Patients With Diffuse Large B-Cell Lymphoma

TAMS

(ECCPC)

CHEMO-CogEx

Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches

GM1 Prophylaxis for Post-chemotherapy Cognitive Impairment in Patients With Early Operable Breast Cancer

CHEMOFOG

Individualized Piano Instruction (IPI) for Improving Cognition in Breast Cancer Survivors.

WINNERS

ICOgnition

ADANC

Electroacupuncture for Chemotherapy-Related Cognitive Impairment

Ashwagandha for Cognitive Dysfunction

Cognitive Stimulation and Chemobrain. An Innovative Intervention for Cancer Survivors

Neuroplasticity-Based Cognitive Remediation for Chemotherapy-Related Cognitive Impairment

ECCO

Chemotherapy-Induced Cognitive Impairment in Ovarian Cancer Patients

Nicotinic Treatment of Post-Chemotherapy Subjective Cognitive Impairment: A Pilot Study

Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release

Computer-Based Training in Patients With Post-Chemotherapy Cognitive Impairment

D-MPH in the Treatment of Fatigue and Neurobehavioral Function Related to Chemotherapy in Adult Cancer Patients